Roxane Paulin Selected Research

Roxane Paulin Research Topics

Disease

19	Pulmonary Arterial Hypertension 04/2022 - 09/2011
13	Neoplasms (Cancer) 03/2021 - 09/2009
13	Vascular Remodeling 03/2021 - 09/2009
10	Pulmonary Hypertension 01/2022 - 11/2011
9	Hypoxia (Hypoxemia) 03/2021 - 09/2012
4	Hypertrophy 10/2020 - 11/2011
4	Right Ventricular Hypertrophy 02/2014 - 09/2012
3	Inflammation (Inflammations) 01/2019 - 02/2014
3	Vascular Diseases (Vascular Disease) 11/2016 - 06/2014
2	Fibrosis (Cirrhosis) 01/2022 - 10/2020
2	Microvascular Rarefaction 10/2020 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 01/2015
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Leukemia 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2016
1	Kidney Neoplasms (Kidney Cancer) 04/2016
1	Heart Failure 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2014
1	Ischemia 05/2014
1	Insulin Resistance 05/2014
1	Disease Susceptibility (Diathesis) 07/2013
1	Vascular System Injuries 09/2009

Drug/Important Bio-Agent (IBA)

11	MonocrotalineIBA 03/2021 - 11/2011
4	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2013
4	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 09/2011
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2018 - 09/2009
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 09/2011
3	CalciumIBA 11/2016 - 01/2013
2	Enhancer of Zeste Homolog 2 ProteinIBA 03/2021 - 10/2020
2	CrizotinibIBA 01/2021 - 01/2021
2	Long Noncoding RNAIBA 10/2020 - 11/2019
2	Therapeutic UsesIBA 01/2019 - 01/2013
2	LectinsIBA 01/2018 - 11/2013
2	MicroRNAs (MicroRNA)IBA 01/2015 - 11/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2013 - 07/2013
2	Glucose (Dextrose)FDA LinkGeneric 11/2013 - 07/2013
2	Dehydroepiandrosterone (DHEA)IBA 11/2011 - 09/2009
2	SteroidsIBA 11/2011 - 09/2009
2	Hormones (Hormone)IBA 11/2011 - 09/2009
1	Poly Adenosine Diphosphate RiboseIBA 04/2022
1	Thyroid Hormone-Binding ProteinsIBA 04/2022
1	prexasertibIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Trifluoperazine (Stelazine)FDA LinkGeneric 03/2021
1	Antipsychotic Agents (Antipsychotics)IBA 03/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 10/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020
1	E2F Transcription FactorsIBA 10/2020
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2020
1	Rubber (Elastica)IBA 01/2020
1	SGI 1776IBA 01/2020
1	apabetaloneIBA 10/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	Checkpoint Kinase 1IBA 01/2019
1	macitentanIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 04/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2017
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 04/2016
1	Generic DrugsIBA 04/2016
1	Sirtuin 3IBA 11/2014
1	Endothelin-1 (Endothelin 1)IBA 06/2014
1	Pioglitazone (Actos)FDA Link 05/2014
1	Insulin (Novolin)FDA Link 05/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2014
1	veliparibIBA 02/2014
1	6- (4- (3- (methylsulfonyl)benzylamino)- 5- (trifluoromethyl)pyrimidin- 2- ylamino)- 3,4- dihydroquinolin- 2(1H)- oneIBA 02/2014
1	Small Interfering RNA (siRNA)IBA 02/2014
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 11/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2013
1	Oxygen (Dioxygen)IBA 07/2013
1	EnzymesIBA 07/2013
1	Uncoupling Protein 2IBA 07/2013
1	Advanced Glycation End ProductsIBA 01/2013
1	LuciferasesIBA 01/2013
1	Reticulin (Reticular Fiber)IBA 01/2013
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2013
1	ursodoxicoltaurineIBA 01/2013
1	Activating Transcription Factor 6IBA 01/2013
1	Drinking WaterIBA 01/2013
1	plumbaginIBA 09/2012
1	Estrogens (Estrogen)FDA Link 08/2012
1	Factor V (Coagulation Factor V)IBA 09/2011

Therapy/Procedure

3	Therapeutics 03/2021 - 06/2014
1	Oral Administration 09/2012